ABCB1 and ABCC11 confer resistance to eribulin in breast cancer cell lines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ABCB1 and ABCC11 confer resistance to eribulin in breast cancer cell lines

Published:2016-08-31 Issue:43 Volume:7 Page:70011-70027
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Oba Takaaki¹,Izumi Hiroto²,Ito Ken-ichi¹

Affiliation:

1. Division of Breast, Endocrine and Respiratory Surgery, Department of Surgery (II), Shinshu University School of Medicine, Matsumoto, Japan

2. Department of Occupational Pneumology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclopenta[b]indoles as novel antimicrotubule agents with antileukemia activity;Toxicology in Vitro;2024-08

2. Involvement of ferroptosis in eribulin-induced cytotoxicity in ovarian clear cell carcinoma;European Journal of Pharmacology;2024-05

3. Trastuzumab-conjugated liposomes for co-delivery of paclitaxel and anti-abcb1 siRNA in HER2-positive breast cancer: In vitro and in vivo evaluations;Journal of Drug Delivery Science and Technology;2024-05

4. Effects of Eribulin on the RNA Content of Extracellular Vesicles Released by Metastatic Breast Cancer Cells;Cells;2024-03-08

5. Liposome-Encapsulated Eribulin Shows Enhanced Antitumor Activity over Eribulin for Combination Therapy with Anti–PD-1 Antibody;Molecular Cancer Therapeutics;2023-01-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP